Glenmark回忆说,由于杂质超过林业发展局的限额,有近150万个ADHD胶囊。 Glenmark recalls nearly 1.5 million ADHD capsules due to an impurity exceeding FDA limits.

格伦马克制药公司正在召回近150万瓶用于治疗美国ADHD的阿托莫克西囊, Glenmark Pharmaceuticals is recalling nearly 1.5 million bottles of Atomoxetine Capsules used to treat ADHD in the US due to an impurity exceeding FDA limits. 2021年1月29日启动的召回行动被归类为第二类,表明有可能出现暂时或可逆转的健康问题,但严重损害的可能性较低。 The recall, initiated on January 29, 2021, is classified as Class II, indicating potential for temporary or reversible health issues but with a low probability of serious harm. 胶囊是在印度制造的。 The capsules were manufactured in India.